166 related articles for article (PubMed ID: 33389029)
1. Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates.
Thouin A; Gastaldi M; Woodhall M; Jacobson L; Vincent A
J Neurol; 2021 May; 268(5):1818-1826. PubMed ID: 33389029
[TBL] [Abstract][Full Text] [Related]
2. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies detection in anti-N-methyl-D-aspartate receptor encephalitis.
Li J; Wang Q; Wang H
Ann Transl Med; 2023 Apr; 11(7):284. PubMed ID: 37090042
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study.
Kelleher E; McNamara P; Dunne J; Fitzmaurice B; Heron EA; Whitty P; Walsh R; Mooney C; Hogan D; Conlon N; Gill M; Vincent A; Doherty CP; Corvin A
Schizophr Res; 2020 Aug; 222():455-461. PubMed ID: 32499165
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.
Zandi MS; Paterson RW; Ellul MA; Jacobson L; Al-Diwani A; Jones JL; Cox AL; Lennox B; Stamelou M; Bhatia KP; Schott JM; Coles AJ; Kullmann DM; Vincent A
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):708-13. PubMed ID: 25246644
[TBL] [Abstract][Full Text] [Related]
6. Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay.
Ramberger M; Peschl P; Schanda K; Irschick R; Höftberger R; Deisenhammer F; Rostásy K; Berger T; Dalmau J; Reindl M
PLoS One; 2015; 10(3):e0122037. PubMed ID: 25815887
[TBL] [Abstract][Full Text] [Related]
7. H-intensity scale score to estimate CSF GluN1 antibody titers with one-time immunostaining using a commercial assay.
Iizuka M; Nagata N; Kanazawa N; Iwami T; Nagashima M; Nakamura M; Kaneko J; Kitamura E; Nishiyama K; Mamorita N; Iizuka T
Front Immunol; 2024; 15():1350837. PubMed ID: 38745654
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
9. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay.
Suh-Lailam BB; Haven TR; Copple SS; Knapp D; Jaskowski TD; Tebo AE
Clin Chim Acta; 2013 Jun; 421():1-6. PubMed ID: 23454475
[TBL] [Abstract][Full Text] [Related]
10. CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis.
Wang R; Guan HZ; Ren HT; Wang W; Hong Z; Zhou D
Seizure; 2015 Jul; 29():137-42. PubMed ID: 26076857
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis.
Guasp M; Módena Y; Armangue T; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31900318
[TBL] [Abstract][Full Text] [Related]
12. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.
Bastiaansen AEM; de Bruijn MAAM; Schuller SL; Martinez-Hernandez E; Brenner J; Paunovic M; Crijnen YS; Mulder MJHL; Schreurs MWJ; de Graaff E; Smitt PAE; Neuteboom RF; de Vries JM; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 34937737
[TBL] [Abstract][Full Text] [Related]
13. The relevance of NMDA receptor antibody-specific index for diagnosis and prognosis in patients with anti-NMDA receptor encephalitis.
Hümmert MW; Jendretzky KF; Fricke K; Gingele M; Ratuszny D; Möhn N; Trebst C; Skripuletz T; Gingele S; Sühs KW
Sci Rep; 2023 Aug; 13(1):12696. PubMed ID: 37542085
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis.
Kaneko A; Kaneko J; Tominaga N; Kanazawa N; Hattori K; Ugawa Y; Moriya A; Kuzume D; Ishima D; Kitamura E; Nishiyama K; Iizuka T
J Neurol; 2018 Mar; 265(3):586-596. PubMed ID: 29356973
[TBL] [Abstract][Full Text] [Related]
15. Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis.
Qin K; Wu W; Huang Y; Xu D; Zhang L; Zheng B; Jiang M; Kou C; Gao J; Li W; Zhang J; Wang S; Luan Y; Yan C; Xu D; Zheng X
BMC Neurol; 2017 Jan; 17(1):1. PubMed ID: 28056870
[TBL] [Abstract][Full Text] [Related]
16. Auto-immune anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: three case reports.
Bashiri FA; Al-Rasheed AA; Hassan SM; Hamad MHA; El Khashab HY; Kentab AY; AlBadr FB; Salih MA
Paediatr Int Child Health; 2017 Aug; 37(3):222-226. PubMed ID: 27329512
[TBL] [Abstract][Full Text] [Related]
17. Testing for
Brooks J; Yarbrough ML; Bucelli RC; Day GS
Can J Neurol Sci; 2020 Jan; 47(1):69-76. PubMed ID: 31566162
[TBL] [Abstract][Full Text] [Related]
18. Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Wang S; Xu C; Sun X; Zhou Y; Shu Y; Xia S; Lu Z; Qiu W; Zhong X; Peng L
J Clin Neurol; 2020 Jul; 16(3):470-479. PubMed ID: 32657069
[TBL] [Abstract][Full Text] [Related]
19. Detection of autoantibody against extracellular epitopes of N-methyl-D-aspartate receptor by cell-based assay.
Takano S; Takahashi Y; Kishi H; Taguchi Y; Takashima S; Tanaka K; Muraguchi A; Mori H
Neurosci Res; 2011 Nov; 71(3):294-302. PubMed ID: 21839784
[TBL] [Abstract][Full Text] [Related]
20. Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis.
Seery N; Butzkueven H; O'Brien TJ; Monif M
Autoimmun Rev; 2022 Apr; 21(4):103057. PubMed ID: 35092831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
